Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders
US9200000B2 · kind B2 · utility
3Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2013 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Nov 1, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the Formula
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.